Redhill Biopharma

RDHL · NASDAQ

$0.5073−$0.0023 (−0.45%)TodayMarket closed · Oct 21, 4:41 AM ET

Prev close $0.5096

About RDHL

RedHill Biopharma Ltd. engages in the development and commercialization of drugs for gastrointestinal (GI), infectious diseases, and oncology. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.

Employees: 35
Headquarters: TEL AVIV-YAFO
Listed: Feb 1, 2011
Sector: Health Care
Industry: Pharmaceuticals
Website: redhillbio.com

Leadership

Redhill Biopharma executives
Name	Title	Since	Age
Dror Ben-Asher	—	2009	58
Razi Ingber	—	—	39
Gilead Raday	—	—	48
Patricia Anderson	—	—	—
Reza Fathi	—	—	68
Rick Scruggs	—	2016	63
June Almenoff	—	—	67
Adi Frish	—	—	54
Guy Goldberg	—	—	47
Shmuel Cabilly	—	—	74
Alla Felder	—	—	49
Kenneth Reed	—	—	69
Eric Swenden	—	—	80
Ofer Tsimchi	—	—	64
Alexandra Okmian	—	2019	—

Suppliers and customers

Price correlation is over one year: 1 means the stocks move together, -1 opposite

Redhill Biopharma suppliers and customers
Company	Relationship	Country	Correlation
Cosmo Pharmaceuticals COPN.SW	Supplier and customer	IE	0.92
Heidelb Ph HPHA.DE	Supplier and customer	DE	0.84
AstraZeneca AZN.L	Supplier and customer	GB	-0.47
7810962 Canada, Inc.	Supplier	CA	—
Apogee Biotechnology Corp.	Supplier and customer	US	—
University of Central Florida	Supplier and customer	US	—
University of Minnesota	Supplier and customer	US	—
United States	Supplier and customer	US	—

Similar companies

Companies in the same industry as Redhill Biopharma

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.